Cetera Investment Advisers Has $38.29 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Cetera Investment Advisers increased its stake in Intuitive Surgical, Inc. by 15.0%, acquiring an additional 10,100 shares during the first quarter.
• Analysts have raised their target prices on Intuitive Surgical, with most projections suggesting a consensus target of $592.05 and an overall rating of "Moderate Buy."
• Intuitive Surgical recently reported earnings of $2.19 per share, significantly surpassing estimates, and showed a 21.4% revenue increase compared to the same quarter last year.

Cetera Investment Advisers increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 15.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,302 shares of the medical equipment provider's stock after buying an additional 10,100 shares during the quarter. Cetera Investment Advisers' holdings in Intuitive Surgical were worth $38,285,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ISRG. Avantax Advisory Services Inc. raised its position in Intuitive Surgical by 2.1% in the 1st quarter. Avantax Advisory Services Inc. now owns 23,334 shares of the medical equipment provider's stock valued at $11,556,000 after purchasing an additional 485 shares during the last quarter. Tufton Capital Management raised its position in Intuitive Surgical by 3.1% in the 1st quarter. Tufton Capital Management now owns 1,003 shares of the medical equipment provider's stock valued at $497,000 after purchasing an additional 30 shares during the last quarter. Brookwood Investment Group LLC bought a new position in Intuitive Surgical in the 1st quarter valued at $697,000. Morling Financial Advisors LLC raised its position in Intuitive Surgical by 16.2% in the 1st quarter. Morling Financial Advisors LLC now owns 767 shares of the medical equipment provider's stock valued at $380,000 after purchasing an additional 107 shares during the last quarter. Finally, Principle Wealth Partners LLC raised its position in Intuitive Surgical by 14.1% in the 1st quarter. Principle Wealth Partners LLC now owns 3,722 shares of the medical equipment provider's stock valued at $1,843,000 after purchasing an additional 460 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president owned 5,224 shares in the company, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director owned 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 7,798 shares of company stock valued at $3,955,331. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on ISRG. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday. BTIG Research lifted their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Piper Sandler reissued an "overweight" rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $592.05.

Intuitive Surgical Trading Up 1.5%

Shares of Intuitive Surgical stock traded up $7.25 during trading on Friday, reaching $495.86. The stock had a trading volume of 1,870,941 shares, compared to its average volume of 1,835,437. The company has a market capitalization of $177.76 billion, a price-to-earnings ratio of 69.16, a P/E/G ratio of 5.20 and a beta of 1.64. The stock has a fifty day moving average price of $529.86 and a two-hundred day moving average price of $535.01. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.78 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.